Gene polymorphism of IL6, DHCR7, VDR, CYP2R1, GC in polycystic ovary syndrome and autoimmune thyroiditis
- Authors: Valikova O.V.1,2, Zdor V.V.3,4, Sarychev V.A.3,5
-
Affiliations:
- Regional Clinical Hospital № 2 Vladivostok
- Cliniс «Plastek surgery» Vladivostok
- Pacific State Medical University
- Cliniс for Diabetes and Endocrine Diseases
- Clinical Hospital “RZD-Medicine”
- Issue: Vol 24, No 4 (2021)
- Pages: 469-476
- Section: SHORT COMMUNICATIONS
- Submitted: 16.07.2021
- Accepted: 20.08.2021
- Published: 15.10.2021
- URL: https://rusimmun.ru/jour/article/view/1056
- DOI: https://doi.org/10.46235/1028-7221-1056-GPO
- ID: 1056
Cite item
Full Text
Abstract
Polycystic ovary syndrome is a common pathology in women of reproductive age, leading to hyperandrogenism, dyslipidemia, diabetes mellitus, ovulation disorder and infertility. Etiopathogenesis of the disease is actively studied, but many of its mechanisms are unclear. The aim was to study the frequency of IL6 and vitamin D receptor gene polymorphisms, blood contents of vitamin D in polycystic ovary syndrome combined with autoimmune thyroiditis.
A total of 192 women were examined, the average age of the patients was 25.5±3.1 years; of these, 130 women had polycystic ovary syndrome. The patients were divided into 2 groups: with polycystic ovary syndrome combined with autoimmune thyroiditis (1st group) and olycystic ovary syndrome without autoimmune thyroid pathology (2nd group); 62 healthy women made up the control sample. The ELISA method was used to determine thyroid stimulating hormone, thyroid hormones, antibodies to thyroid peroxidase, vitamin D, testosterone, estradiol, progesterone, 17-hydroxyprogesterone, luteotropic hormone, follicle-stimulating hormone. Material for genetic studies was isolated from buccal cells. The typing was performed by PCR, and the following polymorphisms were tested: IL6 (rs1800795 SNP), vitamin D receptor (VDR) gene (rs1544410), DHCR7 (rs12785878), GC (rs2282679), CYP2R1 (rs10741657). The results were as follows: polymorphism of IL6, VDR, DHCR7, GC, CYP2R1 genes was revealed in the patients with polycystic ovary syndrome in combination and without concomitant autoimmune thyroiditis. The lowest levels of 25-hydroxyvitamin D in serum were found in the patients with polycystic ovary syndrome and autoimmune thyroiditis.
Polymorphism of IL6 genes, vitamin D receptor, DHCR7, GC, CYP2R1 genes may aggravate the course of polycystic ovary syndrome and requires a more comprehensive study. When polycystic ovary syndrome was combined with autoimmune thyroiditis, the studied gene polymorphisms did not differ significantly from those in patients with polycystic ovary syndrome without autoimmune thyroiditis, thus suggesting greater significance of these genetic factors in pathogenesis of polycystic ovary syndrome. However, more than a half of women with combined endocrine disorders had both homozygous and heterozygous variants of pathological IL6 gene carriage along with lowest vitamin D levels, which may significantly affect immune response and, hence, determine the development of both endocrine disorders.
Keywords
About the authors
O. V. Valikova
Regional Clinical Hospital № 2 Vladivostok;Cliniс «Plastek surgery» Vladivostok
Author for correspondence.
Email: renalex.99@mail.ru
doctor endocrinologist
690012, Russian Federation, Vladivostok, Fastovskya str., 14, apt 184
Phone: 7 (902) 521-77-72
Russian FederationV. V. Zdor
Pacific State Medical University;Cliniс for Diabetes and Endocrine Diseases
Email: victoria.zdor@mail.ru
PhD, MD (Medicine), Leading Research Associate, Сentral Research Laboratory; Clinical Endocrinologist
Russian FederationVladimir Aleksandrovich Sarychev
Pacific State Medical University;Clinical Hospital “RZD-Medicine”
Email: vsarychev1304@gmail.com
Postgraduate Student, Department of Normal and Pathological Physiology; Surgeon
Russian FederationReferences
- Адамян Л.В., Андреева Е.Н., Абсатарова Ю.С., Гаспарян С.А., Геворкян М.А., Григорян О.Р., Гринева Е.Н., Густоварова Т.А., Дедов И.И., Демидова Т.Ю., Зайдиева Я.Д., Карахалис Л.Ю., Лизнева Л.В., Мельниченко Г.А., Соболева Е.Л., Спиридонова Н.В., Сутурина Л.В., Тарасова М.А., Уварова Е.В., Филиппов О.С., Хамошина М.Б., Чернуха Г.Е., Шереметьева Е.В., Ярмолинская М.И. Синдром поликистозных яичников в репродуктивном возрасте (современные подходы к диагностике и лечению): Клинические рекомендации (протокол лечения). М.: Минздрав России, 2016. 22 с.
- Дедов И.И., Мельниченко Г.А., Герасимов Г.А., Фадеев В.В., Петунина Н.А, Александрова Г.Ф., Трошина Е.А., Кузнецов Н.С., Ванушко В.Э. Клинические рекомендации Российской Ассоциации Эндокринологов по диагностике и лечению аутоиммунного тиреоидита у взрослых. М.: Российская ассоциация эндокринологов; ФГБУ «Эндокринологический научный центр» МЗ РФ, 2013. 2 с.
- Пигарова Е.А., Рожинская Л.Я., Белая Ж.Е., Дзеранова Л.К., Каронова Т.Л., Ильин А.В., Мельниченко Г.А., Дедов И.И. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых // Проблемы эндокринологии, 2016. T. 62, № 4. С. 60-84.
- Сутурина Л.В. Синдром поликистозных яичников в XXI веке // Акушерство и гинекология: новости, мнения, обучение, 2017. № 3. С. 86-90.
- Chen L., Zhang Z., Huang J., Jin M. Association between rs1800795 polymorphism in the interleukin-6 gene and the risk of polycystic ovary syndrome: A meta-analysis. Medicine (Baltimore), 2018, Vol. 97, no. 29, e11558. doi: 10.1097/MD.0000000000011558.
- Haldar D., Agrawal N., Patel S., Kambale P.R., Arora K., Sharma A., Tripathi M., Batra A., Kabi B.C. Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study. Eur. J. Nutr. , 2018, Vol. 57, no. 2, pp. 703-711.
- He C., Lin Z., Wagner-Robb S., Ezeamama A.E. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients, 2015, Vol. 7, no. 6, pp. 4555-4577.
- Kowalczyk K., Franik G., Kowalczyk D., Pluta D., Blukacz Ł., P Madej P. Thyroid disorders in polycystic ovary syndrome. Eur. Rev. Med. Pharmacol. Sci., 2017, Vol. 21, no. 2, pp. 346-360.
- Krul-Poel Y., Koenders P.P., Steegers-Theunissen R.P., TenBoekel E., Ter Wee M.M., Louwers Y., Lips P., Laven J.S.E., Simsek S. Vitamin D and metabolic disturbances in Polycystic ovary syndrome (PCOS): a crosssectional study. PLoS One, 2018, Vol. 13, no. 12, e0204748. doi: 10.1371/journal.pone.0204748.
- Lerchbaum E., Rabe Th. Vitamin D and female fertility. Curr. Opin. Obstet. Gynecol., 2014, Vol. 26, no. 3, pp. 145-150.
- Muscogiuri G., Palomba S., Caggiano M., Tafuri D., Colao A., Orio F. Low 25(OH) Vitamin D Levels are associated with autoimmune thyroid disease in Polycystic Ovary Syndrome. Endocrine, 2016, Vol. 53, no. 2, pp. 538-542.
- Siddamalla S., Reddy T.V., Govatati S., Erram N., Deenadayal M., Shivaji S., Bhanoori M. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women. Gynecol. Endocrinol., 2018, Vol. 34, no. 2, pp. 161-165.
- Trummer C., Schwetz V., Kollmann M., Wölfler M., Münzker J., Pieber T.R., Pilz S., Heijboer A.C., Obermayer-Pietsch B., Lerchbaum E. Effects of Vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Eur. J. Nutr., 2019, Vol. 58, no. 5, pp. 2019-2028.
- Zhang Y., Che L., Zhang M., He J. Common cytokine polymorphisms and predisposition to polycystic ovary syndrome: a meta-analysis. Endocr. J., 2020, Vol. 67, no. 5, pp. 561-567.
- Zore T., Joshi N.V., Lizneva D., Azziz R. Polycystic ovarian syndrome: long-term Health consequences. Semin. Reprod. Med., 2017, Vol. 35, no. 3, pp. 271-281.
- Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., Kiel D.P., Streeten E.A., Ohlsson C., Koller D.L., Peltonen L., Cooper J.D., O’Reilly P.F., Houston D.K., Glazer N.L., Vandenput L., Peacock M., Shi J., Rivadeneira F., McCarthy M.I., Anneli P., de Boer I.H., Mangino M., Kato B., Smyth D.J., Booth S.L., Jacques P.F., Burke G.L., Goodarzi M., Cheung C.L., Wolf M., Rice K., Goltzman D., Hidiroglou N., Ladouceur M., Wareham N.J., Hocking L.J., Hart D., Arden N.K., Cooper C., Malik S., Fraser W.D., Hartikainen A.L., Zhai G., Macdonald H.M., Forouhi N.G., Loos R.J., Reid D.M., Hakim A., Dennison E., Liu Y., Power C., Stevens H.E., Jaana L., Vasan R.S., Soranzo N., Bojunga J., Psaty B.M., Lorentzon M., Foroud T., Harris T.B., Hofman A., Jansson J.O., Cauley J.A., Uitterlinden A.G., Gibson Q., Järvelin M.R., Karasik D., Siscovick D.S., Econs M.J., Kritchevsky S.B., Florez J.C., Todd J.A., Dupuis J., Hyppönen E., Spector T.D. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet, 2010, Vol. 376, pp.180-188.